Flowserve Corporation Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Flowserve Corporation Common Stock trades at $72.28 (market cap $8.85B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Flowserve Corporation Common Stock is far larger — about 3.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Flowserve Corporation Common Stock pays a 1.26% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| FLS | SLS | |
|---|---|---|
Market Cap | $8.85B | $2.27B |
Volume | 1,955,324 | 4,179,659 |
Sector | Industrials | Health |
52-Week High | $92.04 | $15.46 |
52-Week Low | $49.09 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $10.44B | $2.14B |
Dividend Yield | 1.26% | — |
Trailing returns across standard periods
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →